-
公开(公告)号:DK71175A
公开(公告)日:1975-10-20
申请号:DK71175
申请日:1975-02-25
Applicant: HOECHST AG
Inventor: WINKELMANN E , ROLLY H
IPC: C07D333/38
Abstract: Novel 5-cyano-thiophen-2-aldehyde-isothiosemicarbazones are described as well as a process for their manufacture. These compounds are active against viruses and therefore suitable for the prophylaxis and therapy of corresponding infections in humans and animals.
-
公开(公告)号:DK384676A
公开(公告)日:1977-02-27
申请号:DK384676
申请日:1976-08-25
Applicant: HOECHST AG
Inventor: WINKELMANN E , RAETHER W , ROLLY H
IPC: A61K31/165 , A61P31/12 , A61P31/16 , A61P33/02 , A61P43/00 , C07C67/00 , C07C231/00 , C07C231/02 , C07C231/12 , C07C237/00 , C07C237/04 , C07C
-
公开(公告)号:DK519581A
公开(公告)日:1982-05-25
申请号:DK519581
申请日:1981-11-23
Applicant: HOECHST AG
Inventor: WINKELMANN E , RAETHER W , ROLLY H
IPC: C07C46/00 , C07C50/24 , C07C50/34 , C07D211/14 , C07D211/26 , C07D295/116 , C07C
-
公开(公告)号:SE345443B
公开(公告)日:1972-05-29
申请号:SE1419466
申请日:1966-10-19
Applicant: HOECHST AG
Inventor: SCHORR M , WINKELMANN E , ROLLY H
IPC: C07D295/13 , C07C87/62 , C07D29/10 , C07D41/04 , C07D87/26
-
公开(公告)号:NZ213501A
公开(公告)日:1988-04-29
申请号:NZ21350185
申请日:1985-09-17
Applicant: HOECHST AG
Inventor: SEEGER K , FULBERTH W , LEINEWEBER M , OBERMEIER R , ROLLY H
IPC: C07K14/52 , A61K38/21 , C07K14/555 , C07K14/56 , A61K45/02
-
公开(公告)号:GR78224B
公开(公告)日:1984-09-26
申请号:GR810166570
申请日:1981-11-19
Applicant: HOECHST AG
Inventor: WINKELMANN E , RAETER W , ROLLY H
IPC: C07C46/00 , C07C50/24 , C07C50/34 , C07D211/14 , C07D211/26 , C07D295/116
-
公开(公告)号:DK23275A
公开(公告)日:1975-09-15
申请号:DK23275
申请日:1975-01-24
Applicant: HOECHST AG
IPC: A61K35/74 , A61K31/715 , C12P1/04 , C12P19/04 , C12P19/44
Abstract: New lipopolysaccharides comprise chains of O-specific sugars, nuclear polysaccharide and lipid A with a relative fatty acid content of: 8-13 (9-11)% dodecanoic acid, 31-39 (33-37)% 2-hydroxydodecanoic acid, 22-29 (23-27)% 3-hydroxydecanoic acid, 23-27 (24-26)% 3-hydroxydodecanoic acid and 0-7(4-6)% other fatty acids. Antiviral agent useful in small doses, e.g. 1/100 of that of interferon, for prophylaxis against e.g. Influenza A0, A2 or B/Lee, Encephalomyocarditis, Vesicular stomatitis, Herpes Simplex 1 viruses etc., and also for therapy (less active). Doses are e.g. 10-100 mcg/kg in nasal sprays or for injection etc.
-
-
-
-
-
-